FindTrial
Sign In

botulinum toxin, Type A

BIOLOGICAL10 trials

Sponsors

Loma Linda University, Anterios Inc., Evolus, Inc., Eirion Therapeutics Inc., Diakonessenhuis, Utrecht

Conditions

Botulinum Toxin, Type aBotulinum Toxins, Type ACrow's FeetGlabellar Frown LinesLateral Canthal LinesLateral Canthal Lines, LCLMuscle StrengthMyalgia of Mastication Muscle

Phase 2

Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
CompletedNCT01358695
Anterios Inc.Crow's Feet, Lateral Canthal Lines
Start: 2011-05-31End: 2012-05-31Updated: 2013-07-01
ET-01 in Subjects With Lateral Canthal Lines
CompletedNCT03326856
Eirion Therapeutics Inc.Crow's Feet, Lateral Canthal Lines
Start: 2017-10-25End: 2018-11-14Updated: 2022-04-21
ET-01 in Subjects With Lateral Canthal Lines, LCL-207
CompletedNCT03655691
Eirion Therapeutics Inc.Crow's Feet, Lateral Canthal Lines
Start: 2018-08-16End: 2019-04-11Updated: 2022-04-21
ET-01 in Subjects With Lateral Canthal Lines, LCL-208
CompletedNCT03839693
Eirion Therapeutics Inc.Crow's Feet, Lateral Canthal Lines
Start: 2018-10-16End: 2019-09-19Updated: 2022-08-23
ET-01 in Subjects With Lateral Canthal Lines, LCL-209
CompletedNCT03912805
Eirion Therapeutics Inc.Crow's Feet, Lateral Canthal Lines, LCL
Start: 2019-02-27End: 2019-10-04Updated: 2022-07-28
ET-01 in Subjects With Lateral Canthal Lines, LCL-210
CompletedNCT04985916
Eirion Therapeutics Inc.Crow's Feet, Lateral Canthal Lines, LCL
Start: 2021-07-19End: 2024-02-08Updated: 2024-12-09

Phase 3

A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001
CompletedNCT02334423
Evolus, Inc.Glabellar Frown Lines
Start: 2015-01-31End: 2015-12-31Updated: 2019-03-27
A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002
CompletedNCT02334436
Evolus, Inc.Glabellar Frown Lines
Start: 2015-01-31End: 2015-12-31Updated: 2019-03-27

Unknown Phase

Assessment of the Effect of Botulinum Toxin in Extensor Digitorum Brevis Via Strain Gauge and Nerve Conduction Studies
CompletedNCT00822523
Loma Linda UniversityBotulinum Toxins, Type A, Muscle Strength
Start: 2009-01-31End: 2015-07-31Updated: 2018-09-05
Botulinum Toxin in the Management of Temporo-mandibular Related Myalgia: a Prospective Study
Enrolling by invitationNCT06677216
Diakonessenhuis, UtrechtBotulinum Toxin, Type a, Myalgia of Mastication Muscle, TMD/Orofacial Pain
Start: 2024-01-26End: 2025-02-01Target: 30Updated: 2024-11-06